ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1901

Severe Foot Symptoms Are Associated with Mortality: The Johnston County Osteoarthritis Project

Yvonne Golightly1, Carolina Alvarez1, Marian Hannan2, Lucy Gates3, Becki Cleveland4, Amanda Nelson1 and Leigh Callahan5, 1University of North Carolina at Chapel Hill, Chapel Hill, NC, 2Marcus Institute for Aging Research, Hebrew SeniorLife, Milton, MA, 3University of Southampton, Southampton, United Kingdom, 4Thurston Arthritis Research Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, 5University of North Carolina Thurston Arthritis Research Center, Chapel Hill, NC

Meeting: ACR Convergence 2021

Keywords: foot, Mortality, pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: Abstracts: Orthopedics, Low Back Pain, & Rehabilitation (1901–1904)

Session Type: Abstract Session

Session Time: 10:30AM-10:45AM

Background/Purpose: Foot symptoms (i.e., pain, aching, and stiffness [PAS]) are common in middle-aged to older adults and are linked to restricted physical activity, poorer physical function and balance, disability, and falls. Their contribution to mortality is not known. This longitudinal analysis examined whether presence and severity of foot symptoms were associated with mortality in a large prospective community-based cohort of Black and White men and women 45+ years old.

Methods: Data were from three study visits (baseline [1999-2004], 1st follow-up [2006-2010], and 2nd follow-up [2013-2015]) of the Johnston County Osteoarthritis Project (JoCoOA). Presence of foot PAS (yes/no) was assessed by the question: “On most days, do you have pain, aching or stiffness in your left/right foot?” Foot PAS severity was recorded as none (referent=0), mild=1, moderate=2, or severe=3. Foot PAS Severity Count summed severity across both feet (0 [none] to 6 [severe in both feet]). All-cause mortality was determined for participants at each follow-up study visit using data from the National Death Index to determine date and cause of death through December 31, 2015. Static covariates (did not change or changed at same rate for all participants over time) were enrollment cohort (original [1991-1997] or enrichment [2003-2004]), birth cohort, age, sex, race, and education level. Time-varying covariates were body mass index (BMI), smoking, alcohol use, minutes/week of moderate/vigorous physical activity, non-steroidal anti-inflammatory drug use, hypertension, cardiovascular disease, diabetes, depressive symptoms, liver disease, knee PAS, and hip PAS. For each foot symptom measure (PAS, PAS severity, PAS Severity Count), separate Cox proportional hazards regression models with covariates were used to estimate adjusted hazard ratios (aHR) and 95% confidence intervals (CI) for the total sample and stratified by sex, race, obesity (BMI< 30 vs. ≥30 kg/m2), and diabetes (test for interaction significant at p< 0.1).

Results: At baseline, mean age was 63 years, 2/3 were women, 1/3 were Black, mean BMI was 31 kg/m2, and 37% had foot PAS (Table 1). Mean follow-up time was 11.8 years, and there were 818 deaths. In adjusted models (Table 2), foot PAS was related to a 16% greater hazard of all-cause mortality (aHR 1.16, 95%CI 0.99, 1.35). Compared to no foot PAS, severe foot PAS was associated with a 59% greater hazard of excess mortality (aHR 1.59, 95% CI 1.23, 2.04). Every 1-unit increase in PAS Severity Count was associated with a 7% greater hazard of all-cause mortality (aHR 1.07, 95% CI 1.03, 1.12). There were no statistically significant differences by sex, race, obesity, or diabetes.

Conclusion: In the JoCoOA, individuals who had greater severity of foot symptoms had increased mortality, independent of confounders. Although mechanisms for this relationship are not yet understood, foot symptoms may contribute to less physical activity and loss of physical function, which over time leads to factors that impact mortality, such as comorbid conditions from increasing BMI or falls from muscle weakness/impaired balance. Strategies to prevent and treat more severe foot pain may be needed to reduce mortality.


Disclosures: Y. Golightly, None; C. Alvarez, None; M. Hannan, None; L. Gates, None; B. Cleveland, None; A. Nelson, Lilly, 1; L. Callahan, None.

To cite this abstract in AMA style:

Golightly Y, Alvarez C, Hannan M, Gates L, Cleveland B, Nelson A, Callahan L. Severe Foot Symptoms Are Associated with Mortality: The Johnston County Osteoarthritis Project [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/severe-foot-symptoms-are-associated-with-mortality-the-johnston-county-osteoarthritis-project/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/severe-foot-symptoms-are-associated-with-mortality-the-johnston-county-osteoarthritis-project/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology